Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

Purpose: The difference between what pharmacy benefit management companies (PBMs) charge prescription benefit plan sponsors and what dispensing pharmacies are paid ("spread") was studied.

representing 80 percent of the PBM market. However, as the House report and others note PBMs have numerous sources of revenue that drive up the cost of medicines. These include rebates from ...

Despite traditional PBMs’ lack of transparency, which leaves employers in the dark about their drug spend while generating billions in revenue for the PBMs, most plan sponsors continually renew ...

Regulatory risks around Pharmacy Benefit Management are mitigated by CarelonRx's diversified revenue streams and a healthy margin of safety in my modeling. The recent price dip presents an ...